Novavax Inc (NVAX)
$12.90
0.00 (0.00%)
NVAX Stock Quote Delayed 30 Minutes
NVAX Stock Alert: What to Know as Novavax Names New CEO
Although a change at the top boosted sentiment for Novavax, the harsh reality is that NVAX stock faces a mountain of worries.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
960.85M
PE Ratio
-4.03
EPS
-3.2
Volume (Avg. Vol.)
5,032
Day's Range
-
52-Week Range
$3.53 - $15.00
Dividend & Yield
N/A (N/A)
NVAX Stock Predictions, Articles, and Novavax Inc News
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time to start the day with a breakdown of the biggest pre-market stock movers traders need to know about on Thursday!
Novavax (NVAX) Stock Falls 10% After Ending Agreement With Gavi
Yesterday, Novavax announced it has terminated a key agreement, sending shares of NVAX stock plunging in today's session.
What Is Going on With Novavax (NVAX) Stock Today?
Novavax (NVAX) stock is on the move Friday after regulators in Canada approved the vaccine company's adult booster shot for Covid-19.
Why Are Vaccine Stocks MRNA, PFE, BNTX, NVAX Up Today?
Vaccine stocks are flying higher on Friday on word that Pfizer will quadruple the price of its Covid-19 vaccine. Will others follow suit?
What Is Going on With Novavax (NVAX) Stock Today?
Despite a massive positive catalyst coming out of an FDA approval today, investors in NVAX stock are still seeing downside.
Why Is Novavax (NVAX) Stock in the Spotlight Today?
Novavax (NVAX) stock is on the move Wednesday following positive data from its Phase 3 PREVENT-19 vaccine trial and Study 307.
5 Investors Betting Big on Novavax (NVAX) Stock
NVAX stock is in focus as the company receives a recommendation from the Swiss health agency concerning its Nuvaxovid drug.
Novavax (NVAX) Stock Pops 8% With Vaccine Talks Underway
Today, investors in Novavax and NVAX stock are cheering the start of a major conference on vaccine tech, which Novavax is a part of.
Dear NVAX Stock Fans, Mark Your Calendars for Oct. 11
Shares of NVAX stock are climbing ahead of the World Vaccine Congress Europe 2022, where Novavax will share new vaccine data.
A Shot of NVAX Stock Is NOT What Your Portfolio Needs
Even before Biden's 'pandemic is over' declaration, NVAX stock struggled due to weak demand for Novavax's Covid-19 shots.
Why Is Novavax (NVAX) Stock Falling Today?
Novavax still has cash, but it needs to get approval for another vaccine if NVAX stock is to be worth buying again.
Why Are Vaccine Stocks MRNA, PFE, NVAX, BNTX Down Today?
Vaccine stocks are taking it on the chin following President Biden's comments that the "pandemic is over." What now?
Why Is Novavax (NVAX) Stock Down Today?
Pfizer and Moderna received FDA approval for their omicron-specific booster. NVAX stock is hitting new 52-week lows in response.
Why Is Novavax (NVAX) Stock Plunging 30%?
Shares of NVAX stock are falling after the company cut its revenue outlook in half and delivered a poor Q2 earnings report.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
We're starting off Tuesday with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on today!
The CDC Just Gave Novavax (NVAX) Stock a Big Boost
Novavax stock is up 6% today after the U.S. Centers for Disease Control and Prevention (CDC) approved its two-dose Covid-19 vaccine for use in adults.
